Tower Research Capital (TRC)’s Quantum Biopharma Class B Subordinate Voting Shares QNTM Stock Holding History
Bought
Maintained
Sold
Other funds holding QNTM
Tower Research Capital (TRC)'s QNTM Position: Q3 2026 in Review
Tower Research Capital (TRC) opened a new position in Quantum Biopharma Class B Subordinate Voting Shares (QNTM) in Q3 2026: 115 shares worth $414. The stake represents ﹤0.01% of the portfolio and ranks #5582 among its holdings. This is a return to the name: Tower Research Capital (TRC) previously reported a position in QNTM as recently as Q1 2026.
Tower Research Capital (TRC) first reported a position in QNTM in Q1 2025 and has held it in 4 quarters since. The position peaked at $24.6K in Q1 2025. 28 funds tracked by Wall St. Rank hold QNTM as of Q3 2026.
- Tower Research Capital (TRC) held 115 shares of Quantum Biopharma Class B Subordinate Voting Shares worth $414 as of Q3 2026.
- Quantum Biopharma Class B Subordinate Voting Shares was a new Tower Research Capital (TRC) position in Q3 2026.
- Quantum Biopharma Class B Subordinate Voting Shares made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q3 2026, its #5582 holding.
- Tower Research Capital (TRC) first reported a position in Quantum Biopharma Class B Subordinate Voting Shares in Q1 2025 and has held it in 4 quarters since.
- Tower Research Capital (TRC)'s Quantum Biopharma Class B Subordinate Voting Shares position peaked at $24.6K in Q1 2025.
- 28 funds tracked by Wall St. Rank held Quantum Biopharma Class B Subordinate Voting Shares as of Q3 2026.
Based on Tower Research Capital (TRC)'s 13F filing for Q3 2026, filed 16 Nov 2026.